MAG
CNMD icon

Millrace Asset Group’s CONMED CNMD Stock Holding History

Millrace Asset Group’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.67M Buy
+23,145
New +$1.63M 1.69% 25

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Millrace Asset Group's CNMD Position: Q3 2024 in Review

Millrace Asset Group opened a new position in CONMED (CNMD) in Q3 2024: 23,145 shares worth $1.67M. The stake represents 1.69% of the portfolio and ranks #25 among its holdings.

290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Millrace Asset Group held 23,145 shares of CONMED worth $1.67M as of Q3 2024.
  • CONMED was a new Millrace Asset Group position in Q3 2024.
  • CONMED made up 1.69% of Millrace Asset Group's portfolio in Q3 2024, its #25 holding.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.